EA201691808A8 - Кортикостероидные композиции для местного применения - Google Patents
Кортикостероидные композиции для местного примененияInfo
- Publication number
- EA201691808A8 EA201691808A8 EA201691808A EA201691808A EA201691808A8 EA 201691808 A8 EA201691808 A8 EA 201691808A8 EA 201691808 A EA201691808 A EA 201691808A EA 201691808 A EA201691808 A EA 201691808A EA 201691808 A8 EA201691808 A8 EA 201691808A8
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- compositions
- local application
- corticosteroid compositions
- corticosteroid
- disorders
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 239000003246 corticosteroid Substances 0.000 title abstract 2
- 208000017520 skin disease Diseases 0.000 abstract 5
- 238000000034 method Methods 0.000 abstract 2
- 238000011200 topical administration Methods 0.000 abstract 2
- 206010048768 Dermatosis Diseases 0.000 abstract 1
- 201000004681 Psoriasis Diseases 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 150000002191 fatty alcohols Chemical class 0.000 abstract 1
- 230000035515 penetration Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
- A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461951165P | 2014-03-11 | 2014-03-11 | |
| PCT/US2015/020031 WO2015138650A1 (en) | 2014-03-11 | 2015-03-11 | Topical corticosteroid compositions |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EA201691808A1 EA201691808A1 (ru) | 2017-02-28 |
| EA201691808A8 true EA201691808A8 (ru) | 2017-04-28 |
Family
ID=52727460
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA201691808A EA201691808A8 (ru) | 2014-03-11 | 2015-03-11 | Кортикостероидные композиции для местного применения |
| EA201692334A EA201692334A1 (ru) | 2014-03-11 | 2015-09-09 | Кортикостероидные композиции для местного применения |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA201692334A EA201692334A1 (ru) | 2014-03-11 | 2015-09-09 | Кортикостероидные композиции для местного применения |
Country Status (13)
| Country | Link |
|---|---|
| US (4) | US20150258119A1 (cg-RX-API-DMAC7.html) |
| EP (2) | EP3116473B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP6487949B2 (cg-RX-API-DMAC7.html) |
| KR (2) | KR101930244B1 (cg-RX-API-DMAC7.html) |
| CN (1) | CN106659682B (cg-RX-API-DMAC7.html) |
| AU (2) | AU2015229403B2 (cg-RX-API-DMAC7.html) |
| BR (1) | BR112016021023A2 (cg-RX-API-DMAC7.html) |
| CA (2) | CA2945943C (cg-RX-API-DMAC7.html) |
| EA (2) | EA201691808A8 (cg-RX-API-DMAC7.html) |
| ES (1) | ES2857602T3 (cg-RX-API-DMAC7.html) |
| MX (2) | MX381164B (cg-RX-API-DMAC7.html) |
| WO (2) | WO2015138650A1 (cg-RX-API-DMAC7.html) |
| ZA (1) | ZA201606704B (cg-RX-API-DMAC7.html) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2637447T3 (es) | 2009-08-31 | 2017-10-13 | Dr. Reddy's Laboratories Ltd. | Formulaciones tópicas que contienen un esteroide |
| US20160184431A1 (en) | 2014-03-11 | 2016-06-30 | Promius Pharma Llc | Topical compositions comprising a corticosteroid |
| WO2017091168A1 (en) * | 2015-11-28 | 2017-06-01 | Pharmacti̇ve İlaç San. Ve Ti̇c. A.Ş. | A topical spray comprising isoconazole nitrate and difluocortolone valerate |
| WO2017123744A1 (en) * | 2016-01-12 | 2017-07-20 | Grace Therapeutics Llc | Betamethasone oral spray formulation and method of use to treat ataxia |
| GB201604316D0 (en) | 2016-03-14 | 2016-04-27 | Avexxin As | Combination therapy |
| US20180028766A1 (en) * | 2016-07-27 | 2018-02-01 | Sun Pharmaceutical Industries Limited | Touch-free topical spray of halobetasol |
| JP2019529555A (ja) | 2016-09-21 | 2019-10-17 | アヴェクシン エーエス | 医薬組成物 |
| US10543177B2 (en) | 2017-04-11 | 2020-01-28 | Kevin Mrohs | Composition and method for treating skin conditions |
| US11620886B2 (en) | 2018-02-19 | 2023-04-04 | Invue Security Products Inc. | Merchandise security system with inductive charging |
| CA3114363A1 (en) * | 2018-09-28 | 2020-04-02 | Joel Studin | Transpore delivery of steroids and large molecules |
| JP7412292B2 (ja) * | 2019-07-10 | 2024-01-12 | 積水化学工業株式会社 | 製剤 |
| WO2021080527A1 (en) * | 2019-10-24 | 2021-04-29 | Pharmacti̇ve İlaç Sanayi̇ Ve Ti̇caret A.Ş. | Topical pharmaceutical compositions containing difluocortolone and isoconazole |
| US20230057282A1 (en) * | 2020-02-11 | 2023-02-23 | Taro Pharmaceutical Industries Ltd. | Compositions comprising desoximetasone and tazarotene |
| US11382863B2 (en) * | 2020-03-04 | 2022-07-12 | Somerset Therapeutics Llc | Injectable suspension comprising an insoluble corticosteroid and a soluble corticosteroid |
| CN113092601B (zh) * | 2021-03-02 | 2022-12-20 | 苏州市药品检验检测研究中心 | 一种化妆品中倍他米松17-丙酸酯及倍他米松21-丙酸酯的检测方法 |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3892856A (en) | 1974-04-10 | 1975-07-01 | Squibb & Sons Inc | Topical steroid formulation |
| US3934013A (en) | 1975-02-21 | 1976-01-20 | Syntex (U.S.A.) Inc. | Pharmaceutical composition |
| US4343798A (en) | 1981-06-23 | 1982-08-10 | The Procter & Gamble Company | Topical antimicrobial anti-inflammatory compositions |
| US4552872A (en) * | 1983-06-21 | 1985-11-12 | The Procter & Gamble Company | Penetrating topical pharmaceutical compositions containing corticosteroids |
| US5422361A (en) * | 1989-12-20 | 1995-06-06 | Schering Corporation | Stable cream and lotion bases for lipophilic drug compositions |
| IT1247529B (it) | 1991-04-24 | 1994-12-17 | Poli Ind Chimica Spa | Composizioni farmaceutiche in forma di schiuma per somministrazione intravaginale, cutanea e orale |
| DE19536246A1 (de) | 1994-09-30 | 1996-04-04 | Juergen Dr Regenold | Pharmazeutische Zusammensetzung |
| GB9504265D0 (en) | 1995-03-03 | 1995-04-19 | Medeva Plc | Corticosteroid-containing pharmaceutical composition |
| IL152486A0 (en) * | 2002-10-25 | 2003-05-29 | Meir Eini | Alcohol-free cosmetic and pharmaceutical foam carrier |
| US20080206161A1 (en) * | 2002-10-25 | 2008-08-28 | Dov Tamarkin | Quiescent foamable compositions, steroids, kits and uses thereof |
| US7820145B2 (en) * | 2003-08-04 | 2010-10-26 | Foamix Ltd. | Oleaginous pharmaceutical and cosmetic foam |
| CL2004001884A1 (es) * | 2003-08-04 | 2005-06-03 | Pfizer Prod Inc | Procedimiento de secado por pulverizacion para la formacion de dispersiones solidas amorfas de un farmaco y polimeros. |
| AU2004313285A1 (en) * | 2003-12-16 | 2005-09-29 | Foamix Ltd | Oleaginous pharmaceutical and cosmetic foam |
| US8460641B2 (en) * | 2004-08-31 | 2013-06-11 | Stiefel Research Australia Pty Ltd | Microemulsion process and composition |
| CN101048136B (zh) * | 2004-08-31 | 2011-06-22 | 施蒂福研究澳大利亚股份有限公司 | 微乳化和亚微米乳化方法和组合物 |
| US20060246098A1 (en) * | 2005-03-16 | 2006-11-02 | Srinivasa Rao | Stable aqueous-based emulsion formulation comprising urea and salicylic acid and method of using same |
| MX2007013230A (es) | 2005-04-25 | 2008-04-17 | Dow Pharmaceutical Sciences Y | Uso de una formulacion en aerosol de clobetasol para tratar psoriasis. |
| GB2443162B (en) | 2006-10-28 | 2011-02-09 | Nupharm Lab Ltd | Betamethasone spray |
| ES2637447T3 (es) * | 2009-08-31 | 2017-10-13 | Dr. Reddy's Laboratories Ltd. | Formulaciones tópicas que contienen un esteroide |
| US8871184B2 (en) * | 2009-10-02 | 2014-10-28 | Foamix Ltd. | Topical tetracycline compositions |
| NL2004437C2 (en) * | 2010-03-19 | 2011-09-20 | Forte Iq B V | Spray-pumpable comprising composition suitable for topical skin application. |
| WO2011156030A2 (en) * | 2010-06-11 | 2011-12-15 | Precision Dermatology, Inc. | High oil-content emollient aerosol foam compositions |
| IN2015DN01009A (cg-RX-API-DMAC7.html) * | 2012-08-10 | 2015-06-12 | Asahi Glass Co Ltd | |
| WO2014145067A1 (en) * | 2013-03-15 | 2014-09-18 | Medicis Pharmaceutical Corporation | Topical compositions of flunisolide and methods of treatment |
| US10111956B2 (en) * | 2013-06-03 | 2018-10-30 | Tolmar, Inc. | Corticosteroid compositions |
-
2015
- 2015-03-11 MX MX2016011842A patent/MX381164B/es unknown
- 2015-03-11 US US14/645,338 patent/US20150258119A1/en not_active Abandoned
- 2015-03-11 BR BR112016021023-9A patent/BR112016021023A2/pt not_active Application Discontinuation
- 2015-03-11 EA EA201691808A patent/EA201691808A8/ru unknown
- 2015-03-11 JP JP2016575611A patent/JP6487949B2/ja not_active Expired - Fee Related
- 2015-03-11 EP EP15712008.0A patent/EP3116473B1/en active Active
- 2015-03-11 WO PCT/US2015/020031 patent/WO2015138650A1/en not_active Ceased
- 2015-03-11 CA CA2945943A patent/CA2945943C/en active Active
- 2015-03-11 KR KR1020167028054A patent/KR101930244B1/ko not_active Expired - Fee Related
- 2015-03-11 AU AU2015229403A patent/AU2015229403B2/en not_active Ceased
- 2015-03-11 ES ES15712008T patent/ES2857602T3/es active Active
- 2015-09-09 AU AU2015385750A patent/AU2015385750B2/en not_active Ceased
- 2015-09-09 CN CN201580035342.XA patent/CN106659682B/zh not_active Expired - Fee Related
- 2015-09-09 JP JP2017516360A patent/JP6535735B2/ja not_active Expired - Fee Related
- 2015-09-09 MX MX2016011841A patent/MX2016011841A/es unknown
- 2015-09-09 EA EA201692334A patent/EA201692334A1/ru unknown
- 2015-09-09 KR KR1020167030914A patent/KR101930246B1/ko not_active Expired - Fee Related
- 2015-09-09 EP EP15884898.6A patent/EP3197432A4/en not_active Withdrawn
- 2015-09-09 WO PCT/US2015/049244 patent/WO2016144381A1/en not_active Ceased
- 2015-09-09 US US14/849,465 patent/US20160030450A1/en not_active Abandoned
- 2015-09-09 CA CA2946201A patent/CA2946201C/en active Active
-
2016
- 2016-09-28 ZA ZA2016/06704A patent/ZA201606704B/en unknown
-
2018
- 2018-04-20 US US15/958,368 patent/US20180250312A1/en not_active Abandoned
-
2019
- 2019-08-27 US US16/551,872 patent/US20200230155A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EA201691808A8 (ru) | Кортикостероидные композиции для местного применения | |
| MX2019005379A (es) | Derivado de pirazolo-heteroarilo, metodo de preparacion y uso medico del mismo. | |
| MX2018012486A (es) | Composiciones para aplicacion topica de compuestos. | |
| CO2017001493A2 (es) | Kits que comprenden inhibidores tigit y agentes anticáncer | |
| NI201600071A (es) | Compuestos de inhibidor de autotaxina | |
| MX2019010757A (es) | Métodos y composiciones relacionados con el tratamiento combinado con antiinflamatorios y nanoportadores sintéticos que comprenden un inmunosupresor. | |
| MX2016004340A (es) | Compuestos heterociclicos y usos de los mismos. | |
| NI201600051A (es) | Combinaciones de inhibidores de histona desacetilasa y farmacos inmunomoduladores | |
| CL2015003801A1 (es) | Formulaciones de anticuerpos y metodos | |
| EA201890218A1 (ru) | Ретиноидные композиции для местного применения | |
| MX2017005861A (es) | Metodos para el control transcripcional objetivo en regiones del super mejorador. | |
| PL410665A1 (pl) | Inhibitory arginazy oraz ich zastosowania terapeutyczne | |
| PH12017500239A1 (en) | Abiraterone acetate formulation and methods of use | |
| MY193312A (en) | Topical formulation for promoting wound healing | |
| NI201600070A (es) | Inhibidores tetracíclicos de autotaxina | |
| MX383254B (es) | Combinacion que comprende un glucocorticoide y edo-s101. | |
| MX2018000262A (es) | Usos terapeuticos de formulaciones de berberina. | |
| MX2017014456A (es) | Usos terapeuticos de l-4-cloroquinurenina. | |
| MX2016008150A (es) | Formulaciones de berberina y usos de las mismas. | |
| GT201400146A (es) | Composiciones farmacéuticas tópicas que comprenden bexaroteno y corticosteroides | |
| BR112018012349A2 (pt) | composição farmacêutica espumante, composição espumante de armazenamento estável e método para tratar um indivíduo com, ou em risco de ter, uma doença, condição ou distúrbio da pele | |
| AR130700A2 (es) | Composiciones de grapiprant y métodos para su utilización | |
| PH12020500472A1 (en) | Autotaxin inhibitor compounds | |
| EA201991866A1 (ru) | Комбинированная терапия | |
| BR112016022318A2 (pt) | método, composição farmacêutica para uso no tratamento de doenças de retina e uso de um anticorpo |